Skin cancer and the solid organ transplant recipient

Area of Science:

• Dermatology
• Transplant Surgery
• Oncology

Background:

• Organ transplant recipients (OTRs) experience longer lifespans due to advanced immunosuppression.
• Cutaneous malignant and premalignant tumors are frequent late complications in OTRs.
• Aggressive skin cancers are notably common in this patient population.

Purpose of the Study:

• To outline essential clinical and pathological correlations for treating diverse skin cancer subtypes in OTRs.
• To detail approaches including risk assessment, malignancy treatment, and prevention strategies.
• To address the evidence gap, as treatment recommendations often rely on expert opinion due to limited studies.

Main Methods:

• Clinical and pathological correlation for diagnosis and treatment planning.
• Risk stratification for secondary skin tumors.
• Surgical excision with margin control (permanent or Mohs technique) for high-risk or large tumors.
• Consideration of novel therapeutic modalities like immune modulators and targeted therapies.
• Patient and public education on skin cancer prevention.

Main Results:

• The primary treatment goal is the complete eradication of skin tumors.
• Treatment modality selection depends on tumor risk (low vs. high) and specific type.
• Excision with margin control is recommended for extensive tumors or those in critical locations.
• Emerging treatments include immune modulators, photodynamic therapy, and genetic defect targeting drugs.
• Prevention education is crucial across all age demographics.

Conclusions:

• Comprehensive management of skin cancer in OTRs requires a multi-faceted approach.
• Treatment strategies must be tailored based on tumor characteristics and patient risk factors.
• Ongoing research and evidence-based guidelines are needed to refine treatment recommendations for OTRs.